Inmedical Therapeutics is centered on the creation of Covergel product, which is intended to avoid difficulties in therapeutic endoscopies.
Inmedical Therapeutics has raised $871K in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Inmedical Therapeutics's investors include Gestion De Capital Riesgo Del Pais Vasco, Viscofan.
Inmedical Therapeutics is headquartered in Vitoria-gasteiz, Spain.
Inmedical Therapeutics is centered on the creation of Covergel product, which is intended to avoid difficulties in therapeutic endoscopies.
Inmedical Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inmedical Therapeutics — Funding & Investors." VCBacked, January 17, 2024, https://www.vcbacked.co/company/inmedical-therapeutics. Accessed August 18, 2026.
VCBacked. (2024). Inmedical Therapeutics — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/inmedical-therapeutics
{{cite web |title=Inmedical Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inmedical-therapeutics |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated